postoperative portal vein thrombosis is a rare complication which occurs most often after hepatobiliary surgery.to date, few cases following laparoscopic cho lecystectomy have been reported. in this paper we present a case of portal vein thrombosis diagnosed with abdominal ct scan on the seventh day following laparoscopic cholecystectomy.the patient was administered therapeutic intravenous hepa...

PurposeTo compare the survival outcomes of postoperative adjuvant aspirin with surgery alone in patients hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT).MethodsFrom June 2013 to July 2015, an open-label, randomized controlled study was conducted resectable HBV-related HCC PVTT. Patients were randomly assigned undergo surgical resection (n = 4...

A 54-year-old man with suspected cirrhosis and a hepatic tumor on positron emission tomography presented to our hospital for assessment and treatment in January 2007. Laboratory tests and diagnostic imaging revealed that the patient had cirrhosis due to hepatitis B virus infection and advanced hepatocellular carcinoma (HCC) along with portal vein tumor thrombosis (PVTT) (T4N1M0, Child's B). Aft...

BACKGROUND/AIMS We investigated the effects of sorafenib monotherapy on advanced hepatocellular carcinoma (HCC) and portal vein tumor thrombosis (PVTT) in a clinical setting. METHODS In total, 143 consecutive patients with unresectable HCC were treated with sorafenib. Among these patients, 30 patients with advanced HCC and PVTT (Vp3 or 4) were treated with sorafenib monotherapy. RESULTS All...

BACKGROUND The prognosis of hepatocellular carcinoma (HCC) after hepatectomy involves many factors. Previous studies have evaluated the separate influences of single factors; few have considered the combined influence of various factors. This paper combines the Bayesian network (BN) with importance measures to identify key factors that have significant effects on survival time. METHODS A data...

BACKGROUND/AIMS Metronomic chemotherapy (MET) is frequently administered in comparatively low doses as a continuous chemotherapeutic agent. The aim of this study was to evaluate the feasibility and overall survival (OS) of MET compared to sorafenib for advanced hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PVTT). METHODS A total of 54 patients with advanced HCC an...

This study aimed to evaluate the efficacy of stereotactic body radiotherapy (SBRT) compared with three-dimensional conformal radiotherapy (3DCRT). Forty-three patients with portal vein tumor thrombosis (PVTT)/inferior vena cava tumor thrombosis (IVCTT) treated with SBRT (27 with CyberKnife (CK) and 16 with TrueBeam (TB)) from April 2013 to December 2014, and 54 treated with 3DCRT from June 2008...

BACKGROUND Portal/hepatic vein tumor thrombosis (PVTT/HVTT) in hepatocellular carcinoma (HCC) is a sign of advanced stage disease and is associated with poor prognosis. This study investigated the surgical outcomes of patients with HCC and PVTT/HVTT to determine the most appropriate surgical treatment strategy for these patients. MATERIALS AND METHODS The study population included 77 HCC pati...

background portal vein thrombosis (pvt) is one of the most common causes of extrahepatic portal hypertension in children, which may follow neonatal umbilical vein catheterization. the incidence rates of catheter-related pvt, in infants and children vary in different studies. this study aimed to determine pvt incidence in the children under 3 years old with a history of neonatal umbilical vein c...

The optimal treatment for hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT) remains controversial. We aimed to investigate the best treatment for patients with HCC with PVTT. From January 2002 to January 2014, the data from all consecutive patients with HCC with PVTT who underwent surgical treatment (ST),TACE,TACE combined with sorafenib (TACE-Sor), or TACE combined with rad...